Artemisia judaica
Artemisia judaica · Accepted scientific name
Scientific literature: Very Sparse (6 studies) · ★☆☆☆☆
Artemisia judaica is a medicinal plant recognized for its diverse range of pharmacological activities, including antiangiogenic, anticancer, antifungal, and antimalarial properties. Scientific investigations into its chemical composition have identified key bioactive compounds such as cirsimaritin, piperitone, 2-ethylhexanoic acid, and santonin. Through various preparations like methanolic extracts, chloroform extracts, crude extracts, and essential oils, researchers explore its therapeutic potential. The plant shows significant promise in addressing complex conditions such as atherosclerosis, diabetes, and parasitic infections due to its antioxidant and antiparasitic effects. Consequently, studying its phytochemical profile remains essential for developing new treatments for various metabolic and infectious diseases.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Northern America
- Plant Parts
- Not available
Classification
Taxonomy
Artemisia judaica is a distinctive member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. It specifically belongs to the order Asterales, which helps define its evolutionary lineage. Furthermore, this plant is a part of the diverse family Asteraceae. Ultimately, it is categorized under the well-known genus Artemisia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Artemisia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Artemisia judaica exhibits a broad geographical presence spanning across several key regions of Africa and Asia. In the African continent, this species is widely distributed throughout Northern Africa, specifically within the borders of Algeria, Egypt, and Libya. Its range also extends into Northeast Tropical Africa, with notable occurrences found in Chad. Beyond the African continent, the plant can be identified within the Asia-Temperate zone. Specifically, it thrives across the Arabian Peninsula, including parts of Saudi Arabia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Artemisia judaica is a resilient plant characterized by its distinct shrub-like growth form. This hardy species grows as a self-supporting structure, maintaining its upright presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Artemisia judaica has emerged as a medicinal plant of significant interest due to its wide range of therapeutic biological activities. Research indicates that its extracts possess notable anticancer properties, including the ability to act as an antiangiogenic agent by inhibiting blood vessel outgrowth essential for tumor growth. Furthermore, the plant demonstrates robust antimicrobial and antifungal capabilities against various bacterial and fungal pathogens. Studies also highlight its potential in the fight against infectious diseases, specifically showing antimalarial activity against Plasmodium falciparum. These diverse pharmacological traits suggest that the phytoconstituents within the plant hold great promise for future drug development.
Compounds
Artemisia judaica is a medicinal plant characterized by a diverse chemical profile that includes several bioactive secondary metabolites. Research has identified that this species contains the dimethoxy flavone cirsimaritin, which has shown significant potential as an anticancer agent. The plant's volatile composition is further enriched by the presence of piperitone and 2-ethylhexanoic acid. Additionally, phytochemical analyses have highlighted the presence of hydroxydavanone and santonin within its various extracts. Together, these constituent relationships underscore the plant's complex pharmacological importance in medicinal applications.
Conditions
Artemisia judaica is traditionally used in the Arabic region to treat conditions such as diabetes and atherosclerosis. The plant's methanolic extract has demonstrated strong antioxidant potential through its ability to treat ABTS radicals. Additionally, the extract exhibits significant lethal toxic effects against the life cycle of the mosquito Aedes aegypti. Research also highlights its potent anti-protozoan activity, specifically showing that it can treat Blastocystis by inhibiting its growth and destroying its forms.
Preparations
Artemisia judaica is prepared as a methanolic extract to evaluate its chemical composition, antioxidant activity, and potential for dengue vector control. It is also prepared as a chloroform (Chl) extract, which has demonstrated superior anticancer and antimicrobial properties compared to other solvents. Research shows the plant is prepared as crude extracts to test antifungal efficacy against various dermatophytes and emerging fungi. Furthermore, Artemisia judaica is prepared as essential oils to investigate its wound healing, antioxidant, and antibiofilm activities. Finally, the plant is prepared as a general extract, known as AjE, which has shown significant neuroprotective effects in murine diabetic models.